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Available online 15 January 2016Abstract Chaetomium atrobrunneum has never been reported to be associated with pneu-
monia. We report the isolation of C. atrobrunneum and Aspergillus fumigatus from a Chinese
elderly patient with fatal pneumonia. Branched, long, and septate hyphae were observed in
potassium hydroxide preparations and Gram-stained smears, and confluent C. atrobrunneum
growth and a few A. fumigatus colonies were found in tracheal aspirates (nine separate occa-
sions). These isolates were identified by conventional morphological methods and by
sequencing the internal transcribed spacer and the D1/D2 domain of the 26S rRNA gene.
The patient responded poorly to the combination therapy of amphotericin B and caspofungin.
This report adds C. atrobrunneum to the list of fungal pneumonia in immunocompromised
hosts. This case report also illustrated the presence of a growth symbiosis between Chaeto-
mium species and A. fumigatus.
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Invasive mold infections are an important cause of mor-
tality in immunocompromised patients.1e3 Although
aspergillosis represents the most common invasive moldby Elsevier Taiwan LLC. This is an open access article under the CC
).
282 H. Wang et al.infection, less commonly encountered molds, such as
the mucormycetes, and Fusarium, Scedosporium,
dematiaceous molds, and Acremonium species are
increasingly being reported.1e3 Chaetomium fungi are
dematiaceous molds found worldwide in soil and plant
debris as a saprophyte; it is also found in warm, dry areas,
including on dung, straw paper, textiles, and bird feathers.4
Chaetomium species affect healthy as well as immuno-
compromised individuals.5e19 Chaetomium globosum is the
most common species; other pathogenic species described
are Chaetomium atrobrunneum, Chaetomium strumarium,
Chaetomium perlucidum, Chaetomium funicolum, and
Chaetomium murorum.5,8,13,14 Clinical features of infection
have included those in association with onychomycosis,
keratitis, sinusitis, lung empyema, pneumonia, and fatal
disseminated cerebral mycosis.5e19 However, C. atro-
brunneum has not been previously reported to be associ-
ated with lung infection.4,14e18Case Report
An 89-year-old man presented at the Emergency Depart-
ment of the Peking Union Medical College Hospital with a 7-
day history of nausea, vomiting, constipation, cough with
scanty sputum, and a noticeably decreased urine output.
His medical history included biliary tract infection, colonic
adenoma, and lung embolism, and he had been bed ridden
for 2 years. Laboratory studies revealed leukocytosis (a
white blood cell count of 15.6 109/L), thrombocytopenia
(116 109/L), an elevated serum creatinine level of
607 mmol/L, and an elevated procalcitonin level of 7.75 ng/
mL. An initial chest X-ray and computed tomography
demonstrated multiple foci of consolidation in both the
lungs and bilateral pleural effusions. Meropenem (200 mg
every 6 hours), moxifloxacin (400 mg daily), and intrave-
nous fluconazole (200 mg daily) were initiated for the
empirical treatment of pneumonia. Over the next 3 days,
he developed septic shock, multiorgan failure, and wors-
ening thrombocytopenia, and required mechanicalFigure 1. Microbiological findings of C. atrobrunneum. (A) Conflu
of A. fumigatus (hollow arrow) found 3 days after the culture of t
with 5% sheep blood. The surface of colonies of C. atrobrunneum wa
to olivaceous 7 days after culture. (B) Lactophenol cotton blue st
showing brown to black perithecia with long, brown, and erect setventilation for respiratory support. Teicoplanin (200 mg
every 3 days) was administered intravenously.
Direct microscopic examination by Gram staining and
potassium hydroxide (KOH) preparations of a tracheal
aspirate sample collected on the 9th hospital day revealed
numerous branched, long, and septate hyphae suggestive of
Aspergillus species. The ZiehleNeelsenstain analyses were
negative for acid-fast bacilli. Cultures obtained from the
tracheal aspirate sample yielded a few colonies of Asper-
gillus fumigatus; in addition, heavy and confluent growth of
Chaetomium species, 3 days later, was identified by routine
morphological methods (Figures 1A and 1B).1 Tests for HIV-
1/HIV-2 antibodies (Abbott, Wiesbaden, Germany) were
negative. Fluconazole was ceased, and it was replaced by
caspofungin 50 mg daily and amphotericin B deoxycholate
(50 mg daily). Meropenem and teicoplanin were dis-
continued, and cefoperazoneesulbactam (3 g every 12
hours) and minocycline were added. The serum 1-3-b-D
glucan test (Gold Mountain River, Tianjin, China) was con-
ducted on four occasions throughout hospitalization, and
each returned a negative result (<10 ng/mL). Over the next
18 days, repeated tracheal aspirate samples were collected
for fungal cultures; confluent growth of Chaetomium spe-
cies along with scattered growth of A. fumigatus was pre-
sent on the trypticase soy agar on 5% sheep blood agar
(Figure 1A) and on Sabouraud dextrose agar (Thermo Fisher
Scientific, Waltham, MA, USA) plates on each occasion from
nine separated tracheal aspirate samples. Due to uncon-
trolled lung infection and progressive multiorgan failure,
the patient died on the 58th hospital day.Microbiological investigation
The surface of the colonies of the Chaetomium isolates on
Sabouraud dextrose agar and sheep blood agar (Figure 1A)
was white in color and woolly in texture on Day 3 of growth,
but became gray to olivaceous after Day 7 of culture.
Lactophenol cotton blue mounts from slide cultures showed
septate hyphae and flask-shaped black peritheciaent growth of C. atrobrunneum (solid arrow) and a few colonies
he bronchial aspirate on the trypticase soy agar supplemented
s white and wooly on the 3rd day after culture and became gray
ain (400 magnification) of slide culture of C. atrobrunneum
ae.
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C. atrobrunneum and A fumigatus in pneumonia 283(Figure 1B). The perithecia contained asci and single-celled
ascospores. Ascospores were oval or lemon-shaped spores
that were olive brown in color and released from the ostiole
of a matured perithecium.
Amplification of the fungal internal transcribed spacer
(ITS) region and the D1/D2 domain of the 26S rRNA gene of
the Chaetomium species was performed as previously
described using the primer pairs ITS1/ITS4 and F63/R635,
respectively.20,21 Species identification was performed by
comparing the obtained ITS and D1/D2 domain sequences
with those contained in the Centraalbureau voor Schim-
melcultures (CBS) Fungal Biodiversity Center database as
well as the GenBank database using the BioloMICSNet and
BLASTn software, respectively.20,21 The results of ITS region
and D1/D2 domain sequencing of the 26S rRNA gene of the
Chaetomium species showed 100% (894/894bp) and 100%
(1016/1016bp) sequence similarity to the ITS and D1/
D2domain sequences of C. atrobrunneum-type strain
CBS379.66, respectively (GenBank accession numbers
JX280771.1 and JX280666.1, respectively).20,21 Identifica-
tion of A. fumigatus was based on conventional morpho-
logical identification methods.22
Minimum inhibitory concentrations (MICs) of vor-
iconazole and amphotericin B, as determined by the Etest
method (bioMe´rieux, Marcy l’Etoile, France), were
0.047 mg/mL and 0.047 mg/mL, respectively, for A. fumi-
gatus, and 0.75 mg/mL and 0.064 mg/mL, respectively, for
C. atrobrunneum. Only two Etest strips of antifungal agents
(voriconazole and amphotericin B) were available in our
laboratory, and MICs were determined after physicians’
request.T
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.Discussion
In the current study, we report a patient who developed
mixed lung infection caused by C. atrobrunneum and A.
fumigatus and who died from uncontrolled lung infection,
despite antifungal therapy, and lung infection-triggered
progressive multiorgan failure. A total of five cases of
human infection due to C. atrobrunneum have previously
been reported (Table 1).4,14e18 In 1998, C. atrobrunneum
was first detected as the pathogen of a cerebral abscess in a
bone marrow transplant recipient, followed by another
case, also of cerebral infection.4,14 In 2010, a case of mixed
cutaneous infection caused by C. atrobrunneum and Clav-
ispora lusitaniae was described in a boy with acute and
severe infection around his left eyelid.15 A further case of
C. atrobrunneum keratitis was described in an adult
male.17 Of the six patients infected with C. atrobrunneum
(with the addition of the present patient here), three have
died: two from cerebral abscesses and one from severe
pneumonia (the present patient) (Table 1). Our patient
extends the spectrum of infection caused by C. atro-
brunneum to include pneumonia. Pneumonia caused by C.
globosum has previously been reported in a patient with
refractory acute myeloid leukemia.12 Interestingly, histo-
logical examination of a lung biopsy specimen revealed only
branched septate hyphae, suggestive of Aspergillus spe-
cies. The finding was similar to that observed in multiple
tracheal aspirates in our patient. In another report, Hoppin
et al19 described a fatal case of lung empyema in a patient
284 H. Wang et al.with acute lymphocytic leukemia where Chaetomium spe-
cies was cultured from the extrapleural fluids on two
separate occasions. However, the species of the fungus was
not specified.
In the present case, the presence of confluent growth of
C. atrobrunneum accompanied by only a few colonies of A.
fumigatus isolated from multiple respiratory secretions
over an 18-day period supported the diagnosis of C. atro-
brunneum pneumonia and A. fumigatus might have played
a helper’s or a stimulator’s role, as suggested earlier.13,23
The genus of Chaetomium requires a cellulose-rich me-
dium for sporulation, and growth of C. globosum has been
noted to be often stimulated in the presence of A. fumi-
gatus, which excretes compounds such as sugar phosphates
and phosphoglyceric acid.13,23 Aru et al23 reported a 73-
year-old woman with chronic maxillary sinusitis and an
infundibulectomy was performed.23 Histological examina-
tion showed necrotic material with hyphae of A. fumigatus
and perithecia of Chaetomium species. Lamoth et al24
demonstrated that with two consecutive ß-D-glucan tests,
the specificity was 98.9% and the estimated negative pre-
dictive value was 94.6%. The repeated (4 separated occa-
sions) negative results for ß-D-glucan test were obtained
during hospitalization, indicating that A. fumigatus is less
likely to be the main pathogen in our patient.24 However,
there were no reports to indicate the usefulness for ß-D-
glucan test for diagnosing invasive infection due to Chae-
tomium species.4,5e19,24,25 Whether 1,3-ß-D-glucan is also a
main cell wall constituent of Chaetomium species is not
known; however, a ß-1,3-glucanase has been detected in
the culture broth of Chaetomium species.26 Consequently,
the heavy growth of C. atrobrunneum from multiple deep
respiratory secretions and the repeatedly negative ß-D-
glucan tests in our patient suggest a more important role of
C. atrobrunneum than A. fumigatus as a pathogen associ-
ated with lung infection. However, pneumonia caused by
dual pathogens (C. atrobrunneum and A. fumigatus) cannot
be excluded because the heavy growth of C. atrobrunneum
might be stimulated by the presence of A. fumigatus in the
respiratory secretions.23
The appropriate regimen for the treatment of lung in-
fections due to Chaetomium species is not well establish-
ed.4,5e19 In our patient, both amphotericin B and
caspofungin were used for the treatment of lung infection,
but a poor response was noted, although the MICs of
amphotericin B against both C. atrobrunneum and A.
fumigatus isolates were low. Two previous studies on
in vitro susceptibility testing of Chaetomium species
demonstrated that these organisms were resistant to flu-
cytosine and fluconazole, and none of the other commonly
used antifungal agents at that time (ketoconazole, itraco-
nazole, miconazole, or amphotericin B) exhibited good
in vitro fungicidal activity against this organism.27,28 Serena
et al28 demonstrated that among the 19 isolates of Chae-
tomium species tested, micafungin was not active at all,
while the geometric mean MICs and minimum effective
concentrations of the three triazoles (voriconazole, rav-
uconazole, and albaconazole) were <0.5 g/mL and <0.4 g/
mL, respectively. As for the seven isolates of C. atro-
brunneum tested, the ranges of MIC and MIC90 were
0.5e4 mg/mL and 2 mg/mL, respectively, to amphotericin B;
64 mg/mL and 64 mg/mL, respectively, to micafungin;0.12e0.5 mg/mL and 0.5 mg/mL, respectively, to vor-
iconazole; 0.06e1 mg/mL and 0.25 mg/mL, respectively, to
ravuconazole; and 0.12e1 mg/mL and 0.25 mg/mL, respec-
tively, to albaconazole.28 Caspofungin was effective as a
salvage therapy in patients with invasive aspergillosis who
were refractory to or intolerant of the standard therapy.29
However, the in vitro activity of caspofungin against
Chaetomium species was limited.11 Serena et al28 also
demonstrated that neither amphotericin deoxycholate,
alone or in combination with itraconazole, nor its liposomal
formulation has been effective in treating patients with
Chaetomium infections.
In summary, we first report a fatal case of pneumonia
most likely caused by C. atrobrunneum, and A. fumigatus
probably played the role of a stimulator in an elderly pa-
tient, although the possibility of dual infection with A.
fumigatus could not be excluded. This report adds C.
atrobrunneum to the list of fungal pneumonia in immuno-
compromised hosts. This case report also illustrated the
presence of growth symbiosis between Chaetomium species
and A. fumigatus.Conflicts of interest
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